Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_assertion description "[Collectively, our data indicate that ERBB2-mediated breast cancer progression requires ?-catenin signaling and can be therapeutically targeted by selective ?-catenin/CBP inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_assertion evidence source_evidence_literature NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_assertion SIO_000772 23720052 NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_assertion wasDerivedFrom befree-2016 NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_assertion wasGeneratedBy ECO_0000203 NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.
- befree-2016 importedOn "2016-02-19" NP1081791.RA2NtIrx_jb6itCFKv-MCjmsmxTqjnuREaJJ5wXi4x-BM130_provenance.